AXIM BIOTECHNOLOGIES, INC. — Income Charts
4 quarters of history · ending 2024-06-30 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$17K
Cost of Revenue
$2K
Gross Profit
$16K
R&D
$4K
SG&A
$473K
D&A
$108K
Operating Income
$-569K
EBITDA
$-461K
Interest Expense
$178K
Interest Income
—
Other Income/Expense
$-2M
Pretax Income
$-2M
Tax Provision
$0
Net Income
$-2M
Gross Margin
90.0%
Operating Margin
-3257.9%
Net Margin
-12986.0%
Effective Tax Rate
0.0%
Deferred Tax Liabilities
—
ETR (Continuing Operations)
0.0%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
11.9%
Operating Lease Cost
$29K
Revenue YoY Variation
76.0%
Income YoY Variation
18.4%
Revenue QoQ Variation
-67.0%
Income QoQ Variation
-41.8%